KHK7580

· Kyowa Kirin Co., Ltd.

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for KHK7580, covering 2015-03-05 to 2022-04-25. Get the full timeline:

Most recent: Clinical Trial Update: Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in Asia [Phase 3]